NEUVOGEN THERAPEUTICS Trademark

Trademark Overview

On Wednesday, April 24, 2024, a trademark application was filed for NEUVOGEN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NEUVOGEN THERAPEUTICS trademark a serial number of 98516970. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, December 31, 2025. This trademark is owned by Neuvogen, Inc.. The NEUVOGEN THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines
neuvogen therapeutics

General Information

Serial Number98516970
Word MarkNEUVOGEN THERAPEUTICS
Filing DateWednesday, April 24, 2024
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, December 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesVaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeuvogen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameNeuvogen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Wednesday, April 24, 2024NEW APPLICATION ENTERED
Thursday, September 5, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, September 5, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, October 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 7, 2024ASSIGNED TO EXAMINER
Friday, November 8, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, November 8, 2024EXAMINERS AMENDMENT E-MAILED
Friday, November 8, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 8, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, November 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 30, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, July 30, 2025SOU EXTENSION 1 FILED
Wednesday, July 30, 2025SOU EXTENSION 1 GRANTED
Thursday, July 31, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 18, 2025SOU TEAS EXTENSION RECEIVED
Monday, August 18, 2025TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 30, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 18, 2025DIVISIONAL REQUEST RECEIVED
Wednesday, December 31, 2025DIVISIONAL PROCESSING COMPLETE
Sunday, August 17, 2025SOU EXTENSION 2 FILED
Wednesday, December 31, 2025SOU EXTENSION 2 GRANTED
Wednesday, December 31, 2025CORRECTED NOA E-MAILED
Thursday, January 1, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics neuvogen vaccines